Nestlé has launched a plant-based drink for toddlers named Little Steps Plantygrow, which can be added to smoothies and shakes.
The company emphasized that the plant-based 'Growing Up Drink,' marketed under its SMA Nutrition range, is not a breast milk substitute, but a nutritional product designed to be enjoyed by toddlers from 1 to 3 years old as part of a varied and balanced diet.
According to Nestlé, Little Steps is a good source of vitamins A, C, B2, and B12, iron, iodine and omega-3, and omega-6. The drink also contains calcium and vitamin D.
Vicky Woods, SMA Nutrition managing director, noted that consumers are increasingly choosing plant-based milk alternatives for themselves and as nutrient-packed options for their toddlers.
The new product is a ready-to-drink liquid that is packaged in resealable cartons for portability. Tesco and Asda carry a 200 ml pack. A 1-liter pack will be available at Asda.


Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
Oil Prices Rebound as Trump Orders Blockade of Sanctioned Venezuelan Tankers
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
OpenAI Explores Massive Funding Round at $750 Billion Valuation
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Asian Stocks Edge Higher as Tech Recovers, U.S. Economic Uncertainty Caps Gains
South Korea Warns Weak Won Could Push Inflation Higher in 2025 



